Company news

GRAIL, Inc. news in 2026

GRAIL, Inc.'s news releases, calls and decks from 2026, newest first.

View company

GRAIL to Present at the UBS Global Healthcare Conference

October 27, 2026

GRAIL to Announce Third Quarter 2026 Financial Results

October 21, 2026

GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026

October 5, 2026

GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference

August 31, 2026

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

August 7, 2026

GRAIL Reports Second Quarter 2026 Financial Results

August 5, 2026

GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference

July 30, 2026

GRAIL to Announce Second Quarter 2026 Financial Results

July 29, 2026

Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans

July 16, 2026

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting

May 31, 2026

GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

May 26, 2026

GRAIL to Present at the 2026 Jefferies Global Healthcare Conference

May 21, 2026

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)

May 7, 2026

GRAIL Reports First Quarter 2026 Financial Results

May 5, 2026

GRAIL to Present at the BofA Securities 2026 Health Care Conference

April 30, 2026

GRAIL to Announce First Quarter 2026 Financial Results

April 22, 2026

GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide

April 7, 2026

Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection

April 1, 2026

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

March 12, 2026

GRAIL to Present at the TD Cowen 46th Annual Health Care Conference

February 24, 2026

GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results

February 19, 2026

Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate

February 19, 2026

GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

February 16, 2026

GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

January 28, 2026

Calls in 2026

Decks in 2026